After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
FibroGen Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of FibroGen Inc is $31.70M. A total of 0.92 million shares were traded on the day, compared to an average of 3.30M shares.
In the most recent transaction, Wettig Thane bought 145,000 shares of FGEN for 0.35 per share on Mar 24 ’25. After the transaction, the CEO now owns 543,329 company shares. In a previous transaction on Mar 20 ’25, Schoeneck James A bought 250,000 shares at 0.35 per share. FGEN shares that Director owns now total 323,722.
Among the insiders who bought shares, Schoeneck James A acquired of 50,000 shares on Mar 21 ’25 at a per-share price of $0.34. This resulted in the Director holding 373,722 shares of FGEN after the transaction. In another insider transaction, Adib Deyaa bought 22,123 shares at $1.17 per share on Jun 12 ’24. Company shares held by the Chief Medical Officer now total 82,123.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, FGEN has a high of $1.74 and a low of $0.18.
As of this writing, FGEN has an earnings estimate of $0.02 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of $0.02 per share and a lower estimate of $0.02.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. FGEN’s latest balance sheet shows that the firm has $405.19M in Cash & Short Term Investments as of fiscal 2021. There were $99.72M in debt and $225.50M in liabilities at the time. Its Book Value Per Share was -$2.24, while its Total Shareholder’s Equity was $229.11M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FGEN is Buy with a score of 4.00.
